nilla, Author at European Medical Journal - Page 10 of 20

Key pharma trends from Cannes Lions

In this episode, Helena and Marc are joined by Claire Gillis, CEO, VMLY&R Health, to discuss the health and pharma highlights from the recent Cannes Lions.

Vaccines and sustainability focus for GSK

In its annual Palio meeting, GSK discusses the growing threat to human health from infectious disease with a group of experts in immunology, vaccinology and epidemiology.

The Value of Evidence-Based Medicine

In this week’s episode, Jonathan is joined by Uwe Gudat, Chief Medical Officer, Aretaeus Sàrl, Geneva, Switzerland.

New AZ study reveals extent of CKD worldwide

Chronic kidney disease is present in one in 10 adults, according to a recent study by AstraZeneca. Read the article for more details.

Cardiovascular catalyst launched by Novartis

A new CVD initiative has been launched by Novartis UK to drive innovation and improve patient access to prevention solutions.

Big pharma vs biotech and the future of marketing

Helena and Marc are joined by Michele Manto, CCO, Galapagos, and Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk.

Sanofi set to slash insulin costs in US

Sanofi is set to cut the pricing of its insulin products in a massive step toward greater access to medicine in the US. Read to find out more.

EuropaBio launches 'Vision for Europe' campaign

EuropaBio has launched a campaign to further Europe’s biotech innovation, investment and excellence, and revolutionise healthcare’s future. Read to find out more.

Unlocking the partnership powerhouse

Are public-private partnerships set to be drivers of innovation across the pharmaceutical industry? Read to find out more.

The unconscious mind of non-adherence

Non-adherence to medication can be caused by a range of factors, including unconscious biases. How can pharma rework current models to ensure they are connecting with patients?